Product Information
DAPAGLIFLOZIN 10 MG TABLET is a generic product labeled by Prasco Laboratories, priced at $0.2049 per EA under NDC 66993045730. Its NADAC has been published 115 times since Apr 17, 2024.
Strength
10 mg/1
Manufacturer
Prasco LaboratoriesNDC
66993045730
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/3/2026
Active Ingredients
DAPAGLIFLOZIN PROPANEDIOLApproval Type
Authorized Generic (NDA)
FDA Application
NDA202293On Market Since
1/3/2024
Pharmacological Classes
Price Statistics
The NADAC for DAPAGLIFLOZIN 10 MG TABLET has been published 115 times since Apr 17, 2024, and over the history we have for it it has declined 98.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2049 per EA |
|---|---|
| All-time high | $11.7784 (May 15, 2024) |
| All-time low | $0.2049 (Jun 3, 2026) |
| 52-week high | $11.5526 |
| 52-week low | $0.2049 |
| Median price | $11.4880 |
| Average price | $11.1080 |
| Largest weekly change | -98.2% (Jun 3, 2026) |
| Weeks tracked | 115 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DAPAGLIFLOZIN 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DAPAGLIFLOZIN 10 MG TABLET, manufactured by Prasco Laboratories, is $0.2049 per EA (NDC 66993045730), effective Jun 24, 2026.
How has the price of DAPAGLIFLOZIN 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for DAPAGLIFLOZIN 10 MG TABLET has declined 98.3%. It has been tracked across 115 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for DAPAGLIFLOZIN 10 MG TABLET?
Since Apr 17, 2024, the NADAC for DAPAGLIFLOZIN 10 MG TABLET has ranged from a low of $0.2049 (Jun 3, 2026) to a high of $11.7784 (May 15, 2024), with a median of $11.4880 per EA.
Are there cheaper alternatives to DAPAGLIFLOZIN 10 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as DAPAGLIFLOZIN 10 MG TABLET, but none are currently priced below it.
Who manufactures DAPAGLIFLOZIN 10 MG TABLET?
DAPAGLIFLOZIN 10 MG TABLET (NDC 66993045730) is labeled by Prasco Laboratories, and CMS classifies it as a generic product.